Table 4 Application of the proposed method for the determination of OMG, MET and EZT in tablets
Drug | OMG | MET | EZT | |||
|---|---|---|---|---|---|---|
Pharmaceutical preparation | Prepared Omaril® tablets (25 mg OMG/tab) | Glucophage® tablets (500 mg MET /tab) | Ezetimibe® tablets (10 mg EZT/tab) | |||
|  | Conc. taken (µg/mL) | %Found a | Conc. taken (µg/mL) | %Found a | Conc. taken (µg/mL) | %Found a |
| Â | 0.20 | 99.75 | 0.5 | 101.06 | 0.10 | 99.6 |
0.25 | 98.56 | 1.0 | 98.41 | 0.20 | 96.80 | |
0.30 | 100.87 | 2.5 | 102.26 | 0.30 | 97.33 | |
0.40 | 99.78 | 5.0 | 98.06 | 0.40 | 99.63 | |
0.50 | 99.36 | 10.0 | 101.34 | 0.50 | 102.92 | |
1.0 | 99.64 | 15.0 | 98.46 | 1.0 | 100.71 | |
1.5 | 101.77 | 20.0 | 101.21 | 1.5 | 99.91 | |
2.0 | 99.15 | 25.0 | 99.62 | 2.0 | 99.80 | |
Mean ± SD |  | 99.86 ± 1.01 |  | 100.05 ± 1.62 |  | 99.59 ± 1.9 |